DE3880754T2 - Perkutanes Präparat mit kontrollierter Abgabe. - Google Patents

Perkutanes Präparat mit kontrollierter Abgabe.

Info

Publication number
DE3880754T2
DE3880754T2 DE88111816T DE3880754T DE3880754T2 DE 3880754 T2 DE3880754 T2 DE 3880754T2 DE 88111816 T DE88111816 T DE 88111816T DE 3880754 T DE3880754 T DE 3880754T DE 3880754 T2 DE3880754 T2 DE 3880754T2
Authority
DE
Germany
Prior art keywords
controlled release
percutaneous preparation
application
skin
contained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88111816T
Other languages
English (en)
Other versions
DE3880754D1 (de
Inventor
Yoshio Ueda
Sotoo Asakura
Yoshio Murakami
Toshiomi Nakate
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of DE3880754D1 publication Critical patent/DE3880754D1/de
Application granted granted Critical
Publication of DE3880754T2 publication Critical patent/DE3880754T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE88111816T 1987-07-24 1988-07-22 Perkutanes Präparat mit kontrollierter Abgabe. Expired - Fee Related DE3880754T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18579087 1987-07-24

Publications (2)

Publication Number Publication Date
DE3880754D1 DE3880754D1 (de) 1993-06-09
DE3880754T2 true DE3880754T2 (de) 1993-10-07

Family

ID=16176941

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88111816T Expired - Fee Related DE3880754T2 (de) 1987-07-24 1988-07-22 Perkutanes Präparat mit kontrollierter Abgabe.

Country Status (9)

Country Link
US (1) US4889721A (de)
EP (1) EP0301424B1 (de)
JP (1) JP2638956B2 (de)
KR (1) KR890001525A (de)
AT (1) ATE88906T1 (de)
AU (1) AU606973B2 (de)
DE (1) DE3880754T2 (de)
ES (1) ES2054744T3 (de)
ZA (1) ZA885069B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015568A2 (en) * 1989-06-02 1990-12-27 Stanley Theodore H Apparatus and methods for noninvasive blood glucose monitoring
US5139023A (en) * 1989-06-02 1992-08-18 Theratech Inc. Apparatus and method for noninvasive blood glucose monitoring
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
US5882675A (en) * 1996-03-09 1999-03-16 Nitto Denko Corporation Percutaneous absorption preparation
US5948433A (en) * 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
GB0309631D0 (en) * 2003-04-28 2003-06-04 Bayer Cropscience Ag Novel process for the preparation of 2-aminomethylpyridine derivatives
US9205062B2 (en) 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US20050202073A1 (en) 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
JP4557596B2 (ja) * 2004-04-28 2010-10-06 積水化成品工業株式会社 外用貼付剤およびその製造方法、並びにその使用方法
WO2006091795A2 (en) * 2005-02-25 2006-08-31 Board Of Regents, The University Of Texas System METHODS AND COMPOSITIONS INVOLVING EXPRESSION OF α1C SUBUNIT OF L-TYPE CALCIUM CHANNELS IN SMOOTH MUSCLE CELLS
WO2007099966A1 (ja) * 2006-02-28 2007-09-07 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収型製剤
KR101239150B1 (ko) * 2012-02-28 2013-03-06 에스케이케미칼주식회사 도네페질-함유 경피흡수제제 및 그의 제조방법
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
JPS5530216B2 (de) * 1974-02-08 1980-08-09
JPS57120518A (en) * 1981-01-19 1982-07-27 Tanabe Seiyaku Co Ltd Preparation of microcapsule
JPS57130914A (en) * 1981-02-04 1982-08-13 Agency Of Ind Science & Technol Prolongation of activity retention
JPS5910513A (ja) * 1982-07-12 1984-01-20 Nitto Electric Ind Co Ltd 医薬製剤
JPS5920374A (ja) * 1982-07-24 1984-02-02 Dia Seiyaku Kk 貼付剤
DK311683A (da) * 1982-07-26 1984-01-27 Fujisawa Pharmaceutical Co Fremgangsmaade til fremstilling af pyridylalkylnitratforbindelser
JPS6081166A (ja) * 1983-10-11 1985-05-09 Fujisawa Pharmaceut Co Ltd ２−ニトロオキシメチル−６−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法
JPS60156607A (ja) * 1984-01-25 1985-08-16 Fujisawa Pharmaceut Co Ltd ２−ニトロオキシメチル−６−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有経皮吸収製剤
JPS6130517A (ja) * 1984-07-20 1986-02-12 Nichiban Co Ltd 三層構造より成る粘膜用貼付剤
JPS6215A (ja) * 1985-02-26 1987-01-06 Fujisawa Pharmaceut Co Ltd ２−ニトロオキシメチル−６−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤
US4749574A (en) * 1986-04-14 1988-06-07 Fujisawa Pharmaceutical Co., Ltd. Sustained-release transdermal delivery preparations
JP2969313B2 (ja) * 1992-10-15 1999-11-02 富士写真フイルム株式会社 放射線画像読取処理条件決定方法

Also Published As

Publication number Publication date
AU1970888A (en) 1989-01-27
EP0301424B1 (de) 1993-05-05
EP0301424A3 (en) 1989-07-12
JP2638956B2 (ja) 1997-08-06
ATE88906T1 (de) 1993-05-15
JPH01104008A (ja) 1989-04-21
ES2054744T3 (es) 1994-08-16
US4889721A (en) 1989-12-26
KR890001525A (ko) 1989-03-27
EP0301424A2 (de) 1989-02-01
AU606973B2 (en) 1991-02-21
DE3880754D1 (de) 1993-06-09
ZA885069B (en) 1989-03-29

Similar Documents

Publication Publication Date Title
DE3880754T2 (de) Perkutanes Präparat mit kontrollierter Abgabe.
DK360489D0 (da) Produkter indeholdende mikro- eller nanopartikler samt fremgangsmaade til deres fremstilling
DE3682457D1 (de) Geraet zur verabreichung von medikamenten an patienten.
DE69208503D1 (de) Mikroverkapseltes Sonnenschutzmittel, das Verfahren zur Herstellung, kosmetische und pharmazeutische Zubereitungen mit Mikrokapseln und Verwendung derselben
DE3751860D1 (de) Verwendung von spezifischem Kernmaterial und Schichten zur Herstellung pharmazeutischer Formulierungen, die stabil gegen die Verfärbung von Omeprazol sind
DE58900340D1 (de) Medizinischer katheter fuer die intravaskulaere langzeitinfusion von medikamenten.
ATE68343T1 (de) Darreichungsform mit kontrollierter freigabe.
IT8848172A0 (it) Impiego di 5ht-3 antagonisti per la preparazione di medicamenti che contrastano gli effetti degli agenti induttori di dipendenza
ATE46513T1 (de) Komplexe aus flavanolignanen mit phospholipiden, herstellung davon und verbundene arzneimitteln.
KR890700360A (ko) 경피 흡수 촉진제 및 이를 함유하는 피부외용 제제
DK581685D0 (da) Transderimalt system for timolol-indgift
DE3880593T2 (de) Arzneizubereitungen mit retardierter Wirkstofffreisetzung.
NO167203C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperazinyl-derivater av puriner.
DE3769707D1 (de) Therapeutisches system mit geregelter wirkstoffabgabe.
KR890701004A (ko) 개선된 생리효과를 가지는 식물의 제조 및 이 식물의 용도
ATE102480T1 (de) Multigranulaere tablette mit verzoegerter freisetzung.
MX9305143A (es) Composiciones nutritivas o medicamentos a base de quitosana, para la administracion de los rumiantes y procedimiento para su preparacion.
NO172802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner
DE68909555D1 (de) Pyridylketoximether-verbindung und diese enthaltende pharmazeutische zusammensetzung.
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
DK164844C (da) Transdermalt effektivt topisk antiallergisk farmaceutisk middel indeholdende azatadin og anvendelse af azatadin til fremstilling af et saadant middel til topisk transdermal behandling af allergiske sygdomme
DE3583234D1 (de) Physiologische mittel zur steigerung der transdermalen freisetzung von arzneimitteln.
EP0052085A3 (de) Pharmazeutische Zusammensetzung, die Vincamin enthält
DE3877499T2 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
EP0288741A3 (de) Pflegemaske

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee